Bone Biologics Corporation

Bone Biologics Corporation is a medical device company specializing in bone regeneration for spinal fusion using the recombinant human protein NELL-1/DBX. Their combination product offers targeted control over bone regeneration, particularly for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has broad applications in surgical specialties such as spinal, orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. Bone Biologics holds a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications.

Products

• NELL-1/DBX Fusion Device